Wordt geladen...
Efficacy and safety of Shenmayizhi decoction as an adjuvant treatment for vascular dementia: Study protocol for a randomized controlled trial
BACKGROUND: Vascular dementia (VaD) is the second most common cause of dementia. The treatment of VaD still remains a challenge so far. Traditional Chinese Herbal medicine is a promising therapy due to their multiple components and targets. Shenmayizhi decoction (SMYZD), a Chinese Herbal prescriptio...
Bewaard in:
| Gepubliceerd in: | Medicine (Baltimore) |
|---|---|
| Hoofdauteurs: | , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Wolters Kluwer Health
2019
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6922576/ https://ncbi.nlm.nih.gov/pubmed/31852125 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000018326 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|